about
Oral infection with the Salmonella enterica serovar Gallinarum 9R attenuated live vaccine as a model to characterise immunity to fowl typhoid in the chickenHelicobacter and salmonella persistent infection strategiesComplex adaptive immunity to enteric fevers in humans: lessons learned and the path forwardRole of T3SS-1 SipD Protein in Protecting Mice against Non-typhoidal Salmonella TyphimuriumRecombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.Immune complex-induced enhancement of bacterial antigen presentation requires Fcgamma receptor III expression on dendritic cells.Salmonella enterica serovar enteritidis ghosts carrying the Escherichia coli heat-labile enterotoxin B subunit are capable of inducing enhanced protective immune responses.Influence of Slc11a1 on the outcome of Salmonella enterica serovar Enteritidis infection in mice is associated with Th polarization.Systemic CD8 T-cell memory response to a Salmonella pathogenicity island 2 effector is restricted to Salmonella enterica encountered in the gastrointestinal mucosa.Evaluation of a Salmonella Strain Lacking the Secondary Messenger C-di-GMP and RpoS as a Live Oral VaccineCancer immunotherapy based on the killing of Salmonella typhimurium-infected tumour cells.Macrophage origin limits functional plasticity in helminth-bacterial co-infectionContribution of Thy1+ NK cells to protective IFN-γ production during Salmonella typhimurium infectionsSalmonella infections: immune and non-immune protection with vaccines.Recombinant Salmonella enterica serovar Typhimurium as a vaccine vector for HIV-1 Gag.The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody responseMouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.The streptomycin mouse model for Salmonella diarrhea: functional analysis of the microbiota, the pathogen's virulence factors, and the host's mucosal immune response.The Role of the spv Genes in Salmonella Pathogenesis.Interaction of a live attenuated Salmonella Gallinarum vaccine candidate with chicken bone marrow-derived dendritic cells.Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice.The dawning era of comprehensive transcriptome analysis in cellular microbiology.Macrophages isolated from chickens genetically resistant or susceptible to systemic salmonellosis show magnitudinal and temporal differential expression of cytokines and chemokines following Salmonella enterica challenge.Resolving Salmonella infection reveals dynamic and persisting changes in murine bone marrow progenitor cell phenotype and function.Cytokine and chemokine responses associated with clearance of a primary Salmonella enterica serovar Typhimurium infection in the chicken and in protective immunity to rechallenge.TLR-mediated loss of CD62L focuses B cell traffic to the spleen during Salmonella typhimurium infection.Contrasting roles of SPARC-related granuloma in bacterial containment and in the induction of anti-Salmonella typhimurium immunity.Overcrowding stress decreases macrophage activity and increases Salmonella Enteritidis invasion in broiler chickens.The inverse association of salmonellosis in infancy with allergic rhinoconjunctivitis and asthma at school-age: a longitudinal study.Heat stress impairs performance and induces intestinal inflammation in broiler chickens infected with Salmonella Enteritidis.Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar typhimurium infection, but not for the initiation of bacterial clearance.A model of persistent Salmonella infection: Salmonella Pullorum modulates the immune response of the chicken from a Th17 towards a Th2-type response.
P2860
Q24816822-8FCABFC8-8535-4F00-A7F5-EE86C3725654Q26997068-0F13005B-3587-43A2-B12D-8338555CA7BBQ27694492-1990673A-056F-4B66-8680-47FE0DE2F142Q28354066-C4F21F82-0093-4AD7-A390-ED3CB32F75E4Q30279061-FE75C5C9-7AAD-4708-8485-27F4143465A6Q33293264-D793453D-E154-49F6-9A95-84A1EA34B621Q33743411-FCDD1781-2508-4B99-800E-32BEAABA5024Q34601879-14509010-62FD-4E3C-9246-A4CA58A9CAF3Q35913406-20F3BA8C-1527-4C3C-9E79-2D7FC86AEAAFQ36107133-CF049D06-9D4D-4749-9C9A-44238AA7951CQ36150409-C564D473-1E9A-46C6-B859-A9E66711AEF7Q36320142-D692E4EE-594D-415E-90CD-DA277E7927D8Q36598235-89A1FBCA-B390-4A4B-B82D-B9149574D6E8Q36761378-10FC8154-4D42-4BAE-9643-8B7E38E268E6Q37235277-1418BD6A-BA89-43ED-AF5E-CE1E30FF0F0BQ37239010-A4D4A35A-9331-4860-8DA2-4F2C0C3522BBQ37880344-B399323E-300F-49F3-A59A-9F8D330E7341Q37968294-D443089C-02E9-45D6-9754-5AEB29F7FA88Q40319960-20755B4F-E5B5-4C14-B72B-D7EC5176FF0DQ40816979-61F7DC8F-3CBA-4854-A0E1-7387B248974CQ41475755-BF5FB812-584E-4EBA-9186-A90F1B4B0262Q41830706-0149C869-6C11-4408-B804-E01E85981408Q41844885-7A8ACB05-D880-48D2-8ACA-F8F31B49E74AQ41857776-FADD3669-4259-440D-9381-3DF5347AC25DQ41865793-78D59C98-8840-4A86-949D-0FEAA5FFDC07Q42557989-7442E5D6-C35E-47AA-8341-140315821E27Q42576505-BDFC805F-4444-4857-848A-C17D02B25361Q45813968-C90943FA-3A31-4780-9DFC-028CF703B2F5Q47819834-66B8F80A-BE85-444B-BE2D-890AEE929DD0Q50024866-A3B6AA4A-F484-49D9-B6C3-4F22C85079C8Q50052089-E94827EA-0384-4ACC-BFC2-744FE4DBBCE7Q54212110-2F7AC596-A5A5-431E-97B7-B4947EA3AF1D
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Development of acquired immunity to Salmonella.
@ast
Development of acquired immunity to Salmonella.
@en
type
label
Development of acquired immunity to Salmonella.
@ast
Development of acquired immunity to Salmonella.
@en
prefLabel
Development of acquired immunity to Salmonella.
@ast
Development of acquired immunity to Salmonella.
@en
P356
P1476
Development of acquired immunity to Salmonella.
@en
P2093
Nathalie Ménager
Pietro Mastroeni
P304
P356
10.1099/JMM.0.05173-0
P577
2003-06-01T00:00:00Z